StonvexLoading…
StonvexStonvexStonvexCore line items from MNST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $8.29B | $7.49B | $7.14B | $6.31B |
Operating Income | $2.42B | $1.93B | $1.95B | $1.58B |
Net Income | $1.91B | $1.51B | $1.63B | $1.19B |
EPS (Diluted) | $1.94 | $1.49 | $1.54 | $1.12 |
Total Assets | $9.99B | $7.72B | $9.69B | $8.29B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $2.09B | $1.53B | $2.30B | $1.31B |
Free Cash Flow OCF − CapEx | $1.97B | $1.66B | $1.50B | $698.97M |
Shares Outstanding | 978.11M | 973.08M | 1.04B | 1.04B |